AS1708727
AS1708727 is an orally active Foxo1 inhibitor, with EC50 values of 0.33 μM and 0.59 μM for G6Pase and PEPCK, respectively[1].
Product Specifications
CAS Number
1253226-93-5
UNSPSC
12352005
Target
Autophagy
Type
Reference compound
Related Pathways
Autophagy
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/as1708727.html
Purity
99.44
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(CC1CCCC1)N(C)C2=CC=C(C(COC3=CC=CC4=C3C=CN=C4)=C2Cl)Cl
Molecular Formula
C24H24Cl2N2O2
Molecular Weight
443.37
References & Citations
[1]Hirotsugu Tanaka, et al. Effects of the Novel Foxo1 Inhibitor AS1708727 on Plasma Glucose and Triglyceride Levels in Diabetic Db/Db Mice. Eur J Pharmacol. 2010 Oct 25;645 (1-3) :185-91.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H8504 96 Tests
Transmembrane protein 39A (TMEM39A) Bovine ELISA Kit
Sign In for Pricing
View Details 
orb1674907-01 20 µg
Recombinant Human Acetylcholine receptor subunit gamma (CHRNG), partial
Sign In for Pricing
View Details orb1674907-02 100 µg
Recombinant Human Acetylcholine receptor subunit gamma (CHRNG), partial
Sign In for Pricing
View Details